Open AccessPhase II and Biomarker Study of Cabozantinib in Metastatic Triple‐Negative Breast Cancer Patients
Author(s) -
Tolaney Sara M.,
Ziehr David R.,
Guo Hao,
Ng Mei R.,
Barry William T.,
Higgins Michaela J.,
Isakoff Steven J.,
Brock Jane E.,
Ivanova Elena V.,
Paweletz Cloud P.,
Demeo Michelle K.,
Ramaiya Nikhil H.,
Overmoyer Beth A.,
Jain Rakesh K.,
Winer Eric P.,
Duda Dan G.
Publication year - 2021
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1002/onco.13809
Subject(s) - medicine , cabozantinib , breast cancer , metastatic breast cancer , triple negative breast cancer , biomarker , oncology , triple negative , cancer , biochemistry , chemistry